| Lucinda Clay Middaugh, MS CCC/SLP | |
|
105 Prater Dr, Georgetown, KY 40324-8663 | |
| (859) 576-5234 | |
| Not Available |
| Full Name | Lucinda Clay Middaugh |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 105 Prater Dr, Georgetown, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093355307 | NPI | - | NPPES |
| NA | Other | NONE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 142344 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lucinda Clay Middaugh, MS CCC/SLP 105 Prater Dr, Georgetown, KY 40324-8663 Ph: (859) 576-5234 | Lucinda Clay Middaugh, MS CCC/SLP 105 Prater Dr, Georgetown, KY 40324-8663 Ph: (859) 576-5234 |
News Archive
People's trust in the government's approval of a safe and effective vaccine against COVID-19 is the biggest driver of vaccine uptake, an Australian study has found.
In this large population study led by Verhoest and colleagues from several European hospitals, the clinical parameters for four patient age groups were evaluated to determine the influence of age at diagnosis on tumor characteristics and outcomes for RCC.
RehabCare Group, Inc. today reported financial results for the quarter and six months ended June 30, 2010. Comparative results for the quarter and six months follow.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A new study has found that very few young women with cancer take steps to preserve their fertility while undergoing cancer therapy. Also, certain groups of young women are more likely to do so than others. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to provide counseling on fertility preservation in reproductive-aged women diagnosed with cancer.
› Verified 3 days ago
Mrs. Michelle Morgan, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 E Main St, Suite 115, Georgetown, KY 40324 Phone: 859-813-2744 | |
Carissa D Yount, MA, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 101 Winding View Trail, Georgetown, KY 04324 Phone: 859-559-5538 Fax: 508-996-3397 | |
Kyler Hays, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 115 Ashton Grove Path, Georgetown, KY 40324 Phone: 502-570-9222 | |
Michael S Hall, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 103 Windsor Path, Suite 4, Georgetown, KY 40324 Phone: 502-863-3870 | |
Dr. Christen Guffey Page, PHD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1138 Lexington Rd Ste 100, Georgetown, KY 40324 Phone: 502-570-3732 Fax: 502-570-3735 | |
Mrs. Cindy Gail Warren, M.A. CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 160 Treetop Ct, Georgetown, KY 40324 Phone: 502-819-8335 | |
Susan C Thomas, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Windsor Path, Suite 3, Georgetown, KY 40324 Phone: 859-588-3709 Fax: 502-603-0622 |